Pharmafile Logo
Pharmafocus logo
Advanced Search

valsartan

Showing 10 posts of 10 posts found.

bottle_of_lies_3d_bookshot_w_logo_

Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world

July 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …

Feature
5204602349_c87b204860_z

FDA approve valsartan generic after shortages of supply

March 13, 2019
Manufacturing and Production, Research and Development FDA, blood pressure drugs, cardiovascular, generic, valsartan

The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply …

News
img_4190-e1376666350337-web

MHRA issues recall of irbesartan blood pressure meds over carcinogen contamination concerns

January 4, 2019
Manufacturing and Production, Medical Communications MHRA, irbesartan, pharma, sartan, valsartan

Following a number of recalls issued in the US and Europe in the latter half of 2018 for the blood …

News
16792957331_d9572dbdf4_z

FDA expands list of valsartan recalls

August 9, 2018
Medical Communications China, FDA, US, heart medication, recall, valsartan

The US Food and Drug Administration (FDA) has expanded a list of products containing valsartan that are to be recalled. …

News
shutterstock_2

EMA issues global recall of heart drugs over cancer risk contamination

July 10, 2018
Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan

Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …

News
allergan

FDA approves Allergan hypertension fixed-dose combo, Byvalson

June 7, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, FDA, US, angiotensin ii, approval, beta blocker, byvalson, hypertension, nebivolol, valsartan

Allergan has announced that the US Food and Drug Administration (FDA) has approved its fixed-dose combination, Byvalson (nebivolol and valsartan), …

News
Novartis image

Novartis sales below forecast in ‘transformative’ year

January 28, 2015
Sales and Marketing Diovan, Exforge, Gleevec, Jimenez, Novartis, amlodipine, q4, valsartan

Novartis’ fourth quarter sales have faded slightly as growth in pharmaceuticals is beaten back by generic competition, and the firm …

News

Novartis heart drug sees stellar results

September 1, 2014
Sales and Marketing Diovan, LCZ696, Novartis, failure, heart, valsartan

Novartis’ new heart pill has produced stellar results in helping patients with heart failure live longer, making it the first …

News
novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

News
Diovan image

Ranbaxy’s Diovan copycat approved in US

June 27, 2014
Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan

Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …

News

Latest content

FDA grants marketing authorisation to DNA test for predisposition to certain cancers

October 2, 2023

Biogen’s biosimilar Tofidence approved by FDA

October 2, 2023

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023